ESC 2020 Guidelines
In the recently published 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation, cMyC is mentioned as the following:
Myosin-binding protein C is more abundant than cardiac troponin and may therefore provide value as an alternative to, or in combination with, cardiac troponin.